RESEARCH TRIANGLE PARK – Tergus Pharma welcomed Gov. Roy Cooper to the dedication of its new headquarters and manufacturing plant in Durham today.
The biopharma company, focused on topical drug development, held an invitation-only opening ceremony to celebrate its new home – a 100,000-square-foot HQ and commercial manufacturing facility. It’s located on a 17-acre site at 4018 Stirrup Creek Road in Durham, just outside Research Triangle Park.
it’s also adding 100 jobs.
Doug Edgeton, CEO of the NC Biotech Center, praised Tergus and its leadership in remarks delivered at the event.
“Since we at the Biotech Center unveiled our Bio Jobs Hub workforce recruitment initiative late last year, we have started to see people from a variety of backgrounds expressing interest in biomanufacturing. As Tergus seeks to double its workforce to 200 people over the next three years, I’m confident that our combined efforts will bring in a growing number of talented and well-trained workers who will find meaningful careers in this important new facility. We’re grateful that Tergus always makes good use of our online Jobs Board … and participates in job fairs, webinars and other networking and career-development events that we sponsor,” he said.
“Tergus is also a strong partner in the NCBioImpact consortium, which provides a bio and pharma manufacturing certificate training program that aligns with industry needs. Tergus provides career opportunities to many students who complete this training, especially from Durham Tech.
“Since Tergus’s founding only nine years ago, it has grown steadily to become a vital part of North Carolina’s cluster of 775 life sciences companies statewide. Of those, Tergus and 130 others are leading the world in biopharma production and manufacturing. Of the 67,000 total life sciences employees statewide, more than 30,000 skilled workers are involved in manufacturing. Bottom line: North Carolina has more biological product manufacturing employees than any other U.S. life sciences hub. That’s Tergus … and that’s huge.”
The job news is the latest in a host of recent economic development announcements that promise more employment across the Triangle region, including Apple, Google, Fidelity Investments and numerous life science firms.
With the $35 million expansion, Tergus, which takes its name from the Latin term for skin, is now a contract development and manufacturing organization (CDMO), providing services from development through commercial manufacturing.
Durham biopharma promises more jobs, moving into new headquarters
“This event marks a significant turning point for us,” says Tergus Pharma Chairman and CEO Vijendra Nalamothu, ahead of the event.
The building houses Tergus’ corporate offices, three research and development laboratories, six commercial GMP manufacturing suites, six filling and packaging suites, and two dedicated HPAPI and hormonal suites.
Tergus says it currently has 100 employees, and plans to add another 100 over the next three years.
(The N.C. Biotech Center contributed to this story.)
